XML 12 R4.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE (LOSS) INCOME - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Income Statement [Abstract]    
Revenues $ 4,820,747 $ 1,942,588
Operating expenses    
General and administrative 805,372 531,391
Rent expense 427,482 178,679
Management fees 132,500 60,000
Professional fees 463,678 132,275
Salaries and wages 1,962,479 712,787
Depreciation expense 540,119 325,351
Total operating expenses 4,331,630 1,940,483
Operating profit 489,117 2,105
Other (expense) income    
Other income 15,760 273,373
Forgiveness of government relief loan 104,368 156,782
Loss on advance (120,000)
Fair value of warrants granted to convertible note holders (854,140)
Penalty on notes and convertible notes (60,075) (9,240)
Interest income 78
Interest expense (588,477) (829,525)
Debt discount (624,683) (1,965,551)
Derivative liability movement 1,526,191
Foreign exchange movements 1,071,320 (34,301)
Net income (loss) before taxation 407,408 (1,854,306)
Taxation (112,220) 280,903
Net income (loss) 295,188 (1,573,403)
Net (income) loss attributable to non-controlling interest (47,308) 30,457
Net income (loss) attributable to Ethema Health Corporation Stockholders’ 247,880 (1,542,946)
Preferred stock dividend (97,782) (100,584)
Net income (loss) available to common shareholders of Ethema Health Corporation 150,098 (1,643,530)
Accumulated other comprehensive (loss) income    
Foreign currency translation adjustment (821,597) 9,813
Total comprehensive loss $ (671,499) $ (1,633,717)
Basic income (loss) per common share $ 0.00 $ 0.00
Diluted income (loss) per common share $ 0.00 $ 0.00
Weighted average common shares outstanding – Basic 3,704,807,230 2,701,590,443
Weighted average common shares outstanding – Diluted 4,276,363,181 2,701,590,443